Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SUSAN G SMOLEN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1609858323
CMS profile
299352
Location
OVIEDO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$335.43

16 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $335.43 16

By paying entity

PY2024 · entire year · sorted by reported total

Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SUSAN G SMOLEN

NPI 1609858323 · CMS profile ID 299352

Allopathic & Osteopathic Physicians / Family Medicine

OVIEDO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1609858323?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SUSAN G SMOLEN, NPI 1609858323, CMS profile ID 299352. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1609858323?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). SUSAN G SMOLEN, NPI 1609858323, CMS profile ID 299352. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1609858323?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
SUSAN G SMOLEN, NPI 1609858323, CMS profile ID 299352, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1609858323?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

16 matching records · $335.43 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 16 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–16 of 16.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
IDORSIA PHARMACEUTICALS US INC $14.7311/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146792672 CMS
Renalytix AI, Inc. $20.1309/11/2024 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 1116760068 CMS
Renalytix AI, Inc. $18.1508/28/2024 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 1116760066 CMS
Esperion Therapeutics, Inc. $19.0008/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1129456124 CMS
SANOFI-AVENTIS U.S. LLC $27.4007/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139728321 CMS
ABBVIE INC. $28.6907/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106128688 CMS
ABBVIE INC. $18.8207/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106128686 CMS
Averitas Pharma Inc. $30.4606/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133447027 CMS
ABBVIE INC. $13.6605/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106128684 CMS
AstraZeneca Pharmaceuticals LP $16.2905/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105718386 CMS
Abbott Laboratories $21.2605/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125150896 CMS
ABBVIE INC. $20.1304/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106128682 CMS
AstraZeneca Pharmaceuticals LP $17.3903/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105224962 CMS
Exact Sciences Corporation $21.4402/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114907969 CMS
Lilly USA, LLC $19.0902/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135434661 CMS
PhotoniCare Inc $28.7901/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1081237692 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $166.21 11
PY2020 $280.97 17
PY2021 $156.58 10
PY2022 $160.27 9
PY2023 $78.33 4
PY2024 $335.43 16
PY2025 $97.51 5

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $104,827.30 39
PY2024 Principal investigator $24,690.00 5
PY2023 Principal investigator $11,989.03 5
PY2022 Principal investigator $431,199.18 114
PY2021 Principal investigator $287,588.81 33
PY2020 Principal investigator $166,680.52 32
PY2019 Principal investigator $248,272.00 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

114 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,080.00 12/31/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH
Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) No dispute reported 06/30/2026 889827483
Principal investigator 1 Abbott Laboratories $26,809.00 11/30/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579749
Principal investigator 1 Abbott Laboratories $700.00 11/30/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579755
Principal investigator 1 Abbott Laboratories $26,809.00 11/30/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579761
Principal investigator 1 Abbott Laboratories $26,809.00 11/30/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579769
Principal investigator 1 Abbott Laboratories $105,820.00 10/14/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579775
Principal investigator 1 GlaxoSmithKline, LLC. $978.12 09/27/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950511
Principal investigator 1 GlaxoSmithKline, LLC. $978.12 09/01/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950497
Principal investigator 1 GlaxoSmithKline, LLC. $1,956.24 09/01/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950519
Principal investigator 1 Abbott Laboratories $635.00 08/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579691
Principal investigator 1 Abbott Laboratories $20.84 08/23/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579685
Principal investigator 1 GlaxoSmithKline, LLC. $2,934.36 08/17/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950521
Principal investigator 1 Abbott Laboratories $786.30 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579557
Principal investigator 1 Abbott Laboratories $635.05 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579563
Principal investigator 1 Abbott Laboratories $187.26 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579569
Principal investigator 1 Abbott Laboratories $4.01 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579575
Principal investigator 1 Abbott Laboratories $8.50 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579581
Principal investigator 1 Abbott Laboratories $2.48 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579587
Principal investigator 1 Abbott Laboratories $22.64 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579593
Principal investigator 1 Abbott Laboratories $1.80 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579599
Principal investigator 1 Abbott Laboratories $8.63 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579605
Principal investigator 1 Abbott Laboratories $22.55 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579611
Principal investigator 1 Abbott Laboratories $14.82 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579615
Principal investigator 1 Abbott Laboratories $1.78 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579621
Principal investigator 1 Abbott Laboratories $0.32 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579627
Principal investigator 1 Abbott Laboratories $4.49 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579633
Principal investigator 1 Abbott Laboratories $2.64 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579639
Principal investigator 1 Abbott Laboratories $10.90 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579645
Principal investigator 1 Abbott Laboratories $301.64 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579651
Principal investigator 1 Abbott Laboratories $40.07 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579719
Principal investigator 1 Abbott Laboratories $13,924.05 08/08/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579725
Principal investigator 1 GlaxoSmithKline, LLC. $2,814.57 07/20/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950489
Principal investigator 1 Abbott Laboratories $4.95 07/13/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579667
Principal investigator 1 Abbott Laboratories $1.63 07/12/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579657
Principal investigator 1 Abbott Laboratories $1.96 07/12/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579661
Principal investigator 1 GlaxoSmithKline, LLC. $734.58 06/22/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950523
Principal investigator 1 Abbott Laboratories $20,450.00 06/20/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579731
Principal investigator 1 Abbott Laboratories $8,294.00 06/14/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578917
Principal investigator 1 GlaxoSmithKline, LLC. $367.29 06/08/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950533
Principal investigator 1 Abbott Laboratories $4.01 06/01/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579309
Principal investigator 1 Abbott Laboratories $14,424.05 05/26/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579303
Principal investigator 1 Abbott Laboratories $4,336.00 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578923
Principal investigator 1 Abbott Laboratories $8,294.00 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578929
Principal investigator 1 Abbott Laboratories $65.00 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578935
Principal investigator 1 Abbott Laboratories $65.00 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578941
Principal investigator 1 Abbott Laboratories $130.00 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578947
Principal investigator 1 Abbott Laboratories $12,270.30 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578953
Principal investigator 1 Abbott Laboratories $12,270.30 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578959
Principal investigator 1 Abbott Laboratories $12,270.30 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578965
Principal investigator 1 Abbott Laboratories $14,424.05 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578969
Principal investigator 1 Abbott Laboratories $14,424.05 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578975
Principal investigator 1 Abbott Laboratories $14,424.05 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578981
Principal investigator 1 Abbott Laboratories $786.30 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578987
Principal investigator 1 Abbott Laboratories $786.30 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578993
Principal investigator 1 Abbott Laboratories $782.82 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914578999
Principal investigator 1 Abbott Laboratories $34.20 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579005
Principal investigator 1 Abbott Laboratories $1,440.77 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579011
Principal investigator 1 Abbott Laboratories $669.76 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579015
Principal investigator 1 Abbott Laboratories $683.96 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579021
Principal investigator 1 Abbott Laboratories $20.82 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579027
Principal investigator 1 Abbott Laboratories $17.73 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579033
Principal investigator 1 Abbott Laboratories $260.46 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579039
Principal investigator 1 Abbott Laboratories $74.09 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579045
Principal investigator 1 Abbott Laboratories $74.09 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579051
Principal investigator 1 Abbott Laboratories $13.70 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579055
Principal investigator 1 Abbott Laboratories $36.06 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579061
Principal investigator 1 Abbott Laboratories $31.88 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579069
Principal investigator 1 Abbott Laboratories $3.99 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579075
Principal investigator 1 Abbott Laboratories $6.03 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579079
Principal investigator 1 Abbott Laboratories $6.03 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579085
Principal investigator 1 Abbott Laboratories $8.01 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579091
Principal investigator 1 Abbott Laboratories $8.01 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579097
Principal investigator 1 Abbott Laboratories $6.01 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579103
Principal investigator 1 Abbott Laboratories $15.23 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579109
Principal investigator 1 Abbott Laboratories $8.01 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579115
Principal investigator 1 Abbott Laboratories $3.19 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579121
Principal investigator 1 Abbott Laboratories $0.64 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579127
Principal investigator 1 Abbott Laboratories $0.64 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579133
Principal investigator 1 Abbott Laboratories $8.01 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579139
Principal investigator 1 Abbott Laboratories $0.64 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579145
Principal investigator 1 Abbott Laboratories $147.77 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579151
Principal investigator 1 Abbott Laboratories $63.49 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579155
Principal investigator 1 Abbott Laboratories $79.66 05/25/2022 Non-covered Recipient Entity
Oviedo Medical Research, LLC
Clinical Evaluation of the Creatinine Test with Untrained Operators in CLIA Waived Environments using Venous Specimens on the i-STAT Crea Cartridge No dispute reported 06/30/2026 914579161
Principal investigator 1 GlaxoSmithKline, LLC. $2,690.82 05/25/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950551
Principal investigator 1 GlaxoSmithKline, LLC. $4,403.52 05/11/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950543
Principal investigator 1 ABBVIE INC. $1,580.00 05/04/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH
Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C No dispute reported 06/30/2026 889789517
Principal investigator 1 GlaxoSmithKline, LLC. $6,907.23 04/25/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950535
Principal investigator 1 GlaxoSmithKline, LLC. $1,924.56 04/21/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950549
Principal investigator 1 GlaxoSmithKline, LLC. $1,924.56 04/06/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950513
Principal investigator 1 GlaxoSmithKline, LLC. $1,557.27 04/06/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950515
Principal investigator 1 GlaxoSmithKline, LLC. $367.29 04/06/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950517
Principal investigator 1 GlaxoSmithKline, LLC. $1,924.56 04/06/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950529
Principal investigator 1 GlaxoSmithKline, LLC. $3,250.17 03/16/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950491
Principal investigator 1 GlaxoSmithKline, LLC. $4,363.92 03/09/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950531
Principal investigator 1 GlaxoSmithKline, LLC. $2,651.22 03/09/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950545
Principal investigator 1 Allergan, Inc. $5,549.40 03/08/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 864373217
Principal investigator 1 Allergan, Inc. $2,482.90 03/08/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 864373535
Principal investigator 1 Allergan, Inc. $1,501.00 03/01/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 864371721
Principal investigator 1 GlaxoSmithKline, LLC. $1,557.27 02/22/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950493
Principal investigator 1 GlaxoSmithKline, LLC. $1,325.61 02/22/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950495
Principal investigator 1 GlaxoSmithKline, LLC. $734.58 02/22/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950501
Principal investigator 1 GlaxoSmithKline, LLC. $1,692.90 02/22/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950507
Principal investigator 1 Allergan, Inc. $969.95 02/17/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 864370013
Principal investigator 1 GlaxoSmithKline, LLC. $3,181.86 02/09/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950525
Principal investigator 1 GlaxoSmithKline, LLC. $734.58 02/09/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950541
Principal investigator 1 GlaxoSmithKline, LLC. $734.58 01/24/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950499
Principal investigator 1 GlaxoSmithKline, LLC. $2,690.82 01/24/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950505
Principal investigator 1 GlaxoSmithKline, LLC. $367.29 01/24/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950509
Principal investigator 1 GlaxoSmithKline, LLC. $1,101.87 01/24/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950527
Principal investigator 1 GlaxoSmithKline, LLC. $367.29 01/24/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950537
Principal investigator 1 GlaxoSmithKline, LLC. $1,692.90 01/24/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950539
Principal investigator 1 GlaxoSmithKline, LLC. $1,924.56 01/24/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DEMONSTRA No dispute reported 06/30/2026 943950547
Principal investigator 1 Allergan, Inc. $4,645.50 01/12/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) No dispute reported 06/30/2026 864366721
Principal investigator 1 Allergan, Inc. $6,741.20 01/12/2022 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
Clinical Trial (LIN-MD-66: PED Longterm safety study) No dispute reported 06/30/2026 864366849